Resolian

Resolian, founded in 2008, operates as a specialized business services provider, focusing on delivering world-class scientific solutions across all therapeutic modalities. The company is a fusion of expertise from Alliance Pharma and Drug Development Solutions, aiming to advance pharmaceutical and biotechnology research. Its primary industry classification spans Business Services General and Business Services, indicating a broad application of its specialized capabilities. Resolian serves a B2B clientele, leveraging its integrated knowledge base to support complex scientific endeavors and drug development pipelines.

With a significant operational scale, Resolian generates an annual revenue of $116.2M and employs between 500 - 1,000 professionals. The company maintains a presence across 3 locations, underscoring its geographic reach and operational capacity. This scale allows for comprehensive project management and execution in scientific research and development. To understand the human capital driving these advancements, one can Meet Resolian's team, gaining insight into the expertise and leadership that underpins its service offerings and commitment to scientific excellence.

Resolian's strategic positioning is further defined by its competitive landscape, which includes entities like Allucent and Eurofins Discovery, highlighting its role in the broader contract research organization (CRO) and scientific services market. The company's services are crucial for clients seeking to navigate the intricate stages of therapeutic development. Key hashtags associated with Resolian, such as #25_plus_engineering_and_tech, #50_plus_scientists, and #10_plus_finance, reflect the depth of specialized talent and financial acumen dedicated to its mission.